NIHilist's Immunology

How Immune System works

Showing posts with label MART1. Show all posts
Showing posts with label MART1. Show all posts
Thursday, June 2, 2016

Combination of checkpoint inhibitor and IL-21-primed melanoma-specific T cells produced durable response, "cure", in melanoma patient

›
This week Journal of Experimental Medicine published a  case study of a single melanoma patient who achieved durable response (>5 years...
›
Home
View web version
Powered by Blogger.